Video Capsule Endoscopy in Small-bowel Malignancy: A Multicenter Belgian Study

Urbain, Daniël; Looze, Danny De; Demedts, Ingrid; Louis, Édouard; Dewit, Olivier; Macken, Elisabeth; Gossum, A. Van

doi:10.1055/s-2005-921203

Cited by 78 publications

(59 citation statements)

References 13 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…The mean age of patients with small bowel tumors was 47.1 years, which was lessened by the patients with benign polyps such as Peutz-Jeghers polyps, and the mean age of patients with GISTs/leiomyomata, lymphomas, or adenocarcinomas was above 50 years. Although the mean age of the patients with small bowel tumors was above 60 years in several CE studies [4][5][6][7][8][9][10], the mean age of those patients with small bowel tumors was 53 years in a Japanese DBE study [17], which is comparable with our results. The disagreement is not thought to be because of racial difference but because of the difference of the mean age between patients who received CE and patients who underwent DBE.…”

Section: Discussionsupporting

confidence: 89%

“…In the past, the diagnosis of small bowel tumors was made mainly through SBFT, abdominal CT, or even laparotomy; however, more accurate diagnosis for small bowel tumors became possible after the development of CE and DBE. The frequency of small bowel tumors in patients who receive CE has been reported to be 1.6-8.9% [4][5][6][7][8][9][10], while the frequency in patients who receive DBE is 10.0, 11.5 and 13.9% according to studies performed in Germany, Portugal, and Japan, respectively [15][16][17]. This difference is because DBE is usually performed to confirm abnormal findings that have been detected by other imaging studies, including CE.…”

Section: Discussionmentioning

confidence: 99%

“…Although it is a minimally invasive test, capsule endoscopy enables the diagnosis of various disorders of the small intestine, such as vascular abnormalities, ulcerative lesions, and tumors [4][5][6][7][8][9][10]. However, false positive or false negative results for small bowel tumors are limitations of capsule endoscopy [11][12][13], and capsule retention occasionally occurs.…”

Section: Introductionmentioning

confidence: 99%

See 2 more Smart Citations

Clinical Characteristics of Small Bowel Tumors Diagnosed by Double-Balloon Endoscopy: KASID Multi-Center Study

Lee

Choi

et al. 2011

Dig Dis Sci

View full text Add to dashboard Cite

Background Small bowel tumors are relatively rare, and their confirmative diagnosis before surgery is not easy. Aims This study was performed to investigate the clinical characteristics of patients with small bowel tumors who received double-balloon enteroscopy (DBE). Secondary end points were to evaluate the usefulness and safety of DBE for the diagnosis of patients with suspected SB tumors derived from other previous procedures. Methods We retrospectively analyzed consecutive DBE examinations to explore the small intestine in eight university hospitals over a 5-year period. Results A total of 877 DBE examinations (per oral 487, per anal 390) were performed in 645 patients (405 males, mean age 48.2 years). Small bowel tumors were diagnosed in 112 patients (17.4%), of which 38 patients had benign polyps, 29 had gastrointestinal stromal tumors/leiomyomata, 18 had lymphomas, 14 had adenocarcinomas, five had metastatic or invasive cancers, five had lipomas, and three patients had cystic tumors. The main reasons for DBE among patients with small bowel tumors were obscure gastrointestinal bleeding (OGIB, 40.2%) followed by abnormal imaging study (25.2%). The concordance rate of diagnoses based on DBE with diagnoses based on small bowel follow-through, CT, and capsule endoscopy among patients with small bowel tumors was 68.9% (42/61), 75.3% (70/93), and 78.3% (18/23), respectively. Therapeutic plans were changed due to the DBE results in 64.2% of patients with small bowel tumors. Conclusions Approximately one-sixth of patients who received DBE had small bowel tumors, and the most common reason for DBE among patients with small bowel tumors was OGIB. DBE is a useful method for the 123Dig Dis Sci (2011) 56:2920-2927 DOI 10.1007/s10620-011-1839 confirmative diagnosis of small bowel tumors and has a good clinical impact on therapeutic plans and short-term clinical results.

show abstract

Section: Discussionsupporting

confidence: 89%

Section: Discussionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Clinical Characteristics of Small Bowel Tumors Diagnosed by Double-Balloon Endoscopy: KASID Multi-Center Study

Lee

Choi

et al. 2011

Dig Dis Sci

View full text Add to dashboard Cite

show abstract

“…SB mass lesions are responsible for OGIB in up to 10% of patients [44][45][46][47][48] . Early clinical studies of CE have reported a frequency of SB tumors ranging between 6% and 9% [49][50][51][52][53][54] . This has led to an idea that CE doubled the rate of diagnosing SB tumors.…”

Section: Small Bowel Tumors and Polypsmentioning

confidence: 99%

Five years’ experience with capsule endoscopy in a single center

Kav¹,

Bayraktar²

2009

WJG

View full text Add to dashboard Cite

Capsule endoscopy (CE) is a novel technology that facilitates highly effective and noninvasive imaging of the small bowel. Although its efficacy in the evaluation of obscure gastrointestinal bleeding (OGIB) has been proven in several trials, data on uses of CE in different small bowel diseases are rapidly accumulating in the literature, and it has been found to be superior to alternative diagnostic tools in a range of such diseases. Based on literature evidence, CE is recommended as a first-line investigation for OGIB after negative bidirectional endoscopy. CE has gained an important role in the diagnosis and follow-up of Crohn's disease and celiac disease and in the surveillance of small bowel tumors and polyps in selected patients. Capsule retention is the major complication, with a frequency of 1%-2%. The purpose of this review was to discuss the procedure, indications, contraindications and adverse effects associated with CE. We also review and share our five-year experience with CE in various small bowel diseases. The recently developed balloon-assisted enteroscopies have both diagnostic and therapeutic capability. At the present time, CE and balloon-assisted enteroscopies are complementary techniques in the diagnosis and management of small bowel diseases.

show abstract

“…(Ciresi & Scholten, 1995;DiSario et al, 1994;Lewis, 1994;Lewis et al, 2005;Kariv & Arber 2003). Early clinical studies of CE have reported a frequency of SB tumors ranging between 6% and 9% (Bailey et al,2006;Cobrin et al,2006;de Franchis et al,2004;Estevez et al,2007;Schwartz &Barkin,2007;Urbain et al,2006). This has led to an idea that CE doubled the rate of diagnosing SB tumors.…”

Section: Small Bowel Tumors and Polypsmentioning

confidence: 99%